VNDA
Vanda Pharmaceuticals Inc
4.60$
-1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -106.4% | – | – | – | – | – | -165.1% | – | – | +53.2% | +12.7% | +24.0% | -50.2% | -60.0% | -223.1% | – | |
| – | +12.5% | +35.8% | -0.7% | -7.1% | +168.4% | +28.5% | +7.3% | +8.4% | -9.4% | +44.5% | +386.9% | -12.4% | -74.9% | -0.9% | -2.2% | -1.0% | -0.8% | -3.8% | +10.1% | +170.2% | -111.7% | |
| – | – | – | -99.7% | -31.8% | -16.1% | -55.6% | +10.4% | -25.6% | +12.5% | +27.7% | +35.4% | +7.3% | +22.5% | +11.5% | +15.4% | -0.7% | +15.1% | +5.9% | -13.8% | -11.5% | -23.8% | |
| – | – | – | – | – | – | – | +87.8% | -44.1% | +12.5% | -1,658.2% | – | +5.4% | +21.7% | +7.1% | -712.9% | – | +11.9% | -16.7% | – | – | – | |
| – | +64.8% | +706.1% | -31.7% | -327.0% | – | -110.6% | – | – | – | – | – | -137.7% | – | – | – | +38.1% | -36.6% | +121.9% | -112.3% | – | – | |
| – | -29.6% | +363.8% | -79.4% | +237.7% | +1,171.6% | -100.0% | – | +633.5% | -91.3% | +4,882.4% | -71.2% | -44.3% | +18.3% | +1,424.5% | -96.0% | +76.2% | -69.2% | +23.0% | -43.6% | +27.9% | +103.7% | |
| – | +2,509.8% | – | -693.1% | – | -111.0% | +3,183.7% | – | -38.0% | -174.9% | -64.9% | +121.0% | -62.1% | +0.4% | +985.0% | -37.7% | -39.2% | +84.8% | – | -124.1% | +44.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -52.0% | -1,733.3% | – | -100.4% | – | -32.3% | +1,940.1% | -94.2% | -10.1% | -37.0% | -79.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,184.5% | |
| – | +83.5% | +60.1% | +109.0% | – | – | +133.7% | -99.3% | -52.0% | +415,391.7% | +80.0% | -95.4% | +89.5% | -32.3% | +1,940.1% | -94.2% | -10.1% | -37.0% | -79.3% | -17.6% | -125.6% | +1,774.8% | |
| – | -47.7% | +108.6% | +10.9% | -125.9% | – | -197.9% | – | -98.1% | -2,927.8% | – | – | – | – | – | -158.5% | – | -156.3% | – | -99.0% | -4,330.4% | – | |
| – | – | – | – | – | – | -106.9% | – | – | – | – | – | -195.8% | – | – | +872.9% | +11.2% | +27.4% | -50.8% | -60.3% | -230.8% | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.